Arovella Therapeutics Ltd - ALA share price
About
Arovella Therapeutics Limited, an Australian biotech company, focuses on developing innovative therapies for oncology and central nervous system disorders. Their technologies include iNKT Cell Therapy and DKK1-CAR-iNKT, aiming to treat blood cancers and solid tumors. They also have approvals for Anagrelide in multiple regions and market ZolpiMist for short-term insomnia. Collaboration with Imperial College London enhances their research and development efforts.
Company Profile
Disclaimer: The above financial data is sourced from EODHD and is for informational purposes only. Veye does not guarantee the accuracy or completeness of this data. Investors should conduct their own research and consult with a financial advisor before making investment decisions.
Price Summary
Price Chart
Get Your FREE Report
Discover the Top ASX Stocks to Invest In 2026!
Expert Analysis of Top-Performing ASX Stocks
Market Insights and In-Depth Research
Buy, Sell, And Hold Recommendations
Almost There!
Enter your details to download the report
Success!
Preparing your download...
Latest Reports from Veye
Grab Your FREE Report on Top 5 ASX Stocks to Buy in 2026
Latest Article
